AVCRF) on the road to making actionable health information more accessible

Receive instant alerts for news on your actions. Claim your 1-week free trial for Street Insider Premium here.

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) increases access to innovations in its diagnostic technology in walk-in pharmacy. Recently, the company has expanded from key cities in eastern Canada to locations on the West Coast, where it hopes to diversify the profile of patients using its services. “Addition of five outlets in British Columbia as part of Avricore’s pilot partnership with national drugstore chain Shoppers Drug Mart should serve as a first step in the company’s plans to serve 600 locations by the end of it. 2023 ”, we read in a recent article. In a previous press release, CEO Hector Bremner commented, “We have demonstrated a unique resilience in staying focused on our goal of creating the world’s largest rapid test network in a pharmacy… We are on the right track. way to make actionable health information more accessible. for everyone and significantly expand our network in the coming months. Notably, Avricore’s HealthTab (TM) technology, which was recently extended to provide lab-quality results for prediabetes, “also has the potential to work with a range of new partners to detect other health issues in the field. other populations over time, using the professional skills of neighborhood pharmacists to oversee the process and share data.

To view the full article, visit https://ibn.fm/6iGXy

About Avricore Santé Inc.

Avricore Health is a pharmacy services innovator focused on the acquisition and development of early stage technologies aimed at advancing pharmacy. Through its flagship offering HealthTab (TM), (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid test devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.

NOTICE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements delivered in multiple languages, we’ve got the wire-quality delivery products you’ll need to make sure your next press release grabs the attention of your target audience and doesn’t let go. While our competitors seek to offer you hidden fees and restrictive word limits, InvestorWire is keeping things transparent. We offer UNLIMITED Words on all national outings. While other communications services can provide a basic review of your release, InvestorWire helps you do your best with Improved press release.

At our competitors, the job is done the second your exit goes on the wire. Not with InvestorWire. We include follow-up coverage of every release taking advantage of the ever-growing audience for the 50+ brands who make up the InvestorBrandNetwork.

Make the most of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please review the full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever posted or republished: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, California 90046
310.299.1717 Office
[email protected]

InvestorWire is part of InvestorBrandNetwork.

Comments are closed.